IGC Pharma, Inc. - Director's Dealing 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IGC Pharma, Inc. (IGC)
CIK: 0001326205
Period of Report: 2026-02-03

Reporting Person: Mukunda Ram (Director, CEO)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-03	Common Stock	M	50000	$0.0	Acquired	860752	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-03	Restricted Stock Units	$	A	16667	Acquired		Common Stock (16667)	Indirect
2026-02-03	Restricted Stock Units	$	A	66666	Acquired		Common Stock (66666)	Indirect

F1: On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to immediate vesting.

F2: On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting on March 31, 2026.

F3: On February 3, 2026, the Reporting Person's spouse were granted RSUs subject to vesting equally over two years starting on March 31, 2026.

F4: Each restricted stock unit represents a right to receive one share of IGC common stock.